Shaking the Foundations: The Forces That Will Reshape Biopharma’s Future

Unpack critical considerations across key disruptive areas biopharma industry stakeholders are paying attention to in the year ahead.

By Brian Abrahams, M.D., Luca Issi, Ph.D., Leonid Timashev & Lisa Walter
| 3 min read

Our experts

Brian Abrahams, M.D.
Brian Abrahams, M.D.
Managing Director, Co-Head of Biotechnology Research,
Luca Issi, Ph.D.
Luca Issi, Ph.D.
Senior Biotechnology Research Analyst,
Leonid Timashev
Leonid Timashev
Biotechnology Analyst, RBC Capital Markets,
Lisa Walter
Lisa Walter
Vice President, Capital Markets Advisory

 

Stay informed

Get the latest insights and news from RBC Capital Markets delivered to your inbox.